(Q48192079)

9 February 2018

title

Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy (English)

1 reference

9 February 2018

1 reference

1 reference

Fumiaki Mori

1

1 reference

9 February 2018

Yue-Shan Piao

2

1 reference

9 February 2018

Shintaro Hayashi

3

1 reference

9 February 2018

Hideo Fujiwara

4

1 reference

9 February 2018

Masato Hasegawa

5

1 reference

9 February 2018

Makoto Yoshimoto

6

1 reference

9 February 2018

Takeshi Iwatsubo

7

1 reference

9 February 2018

Hitoshi Takahashi

8

1 reference

9 February 2018

Koichi Wakabayashi

9

1 reference

9 February 2018

publication date

1 August 2003

1 reference

9 February 2018

Journal of Neuropathology & Experimental Neurology

published in

1 reference

9 February 2018

volume

62

1 reference

9 February 2018

issue

8

1 reference

9 February 2018

page(s)

812-819

1 reference

9 February 2018

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Widespread alterations of alpha-synuclein in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Multiple-system atrophy: a new alpha-synuclein disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

alpha-Synuclein is phosphorylated in synucleinopathy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Hippocampal pathology in diffuse Lewy body disease using ubiquitin immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Metabolic changes following subthalamotomy for advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Cell death mechanisms in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

Myelin degeneration in multiple system atrophy detected by unique antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.8.812

21 January 2018

Identifiers

DOI

10.1093/JNEN/62.8.812

1 reference

9 February 2018

1 reference

9 February 2018